Oct 12 (Reuters) - BiVictriX Therapeutics PLC:
* EXTENDED SURVIVAL RATES REPORTED WITH BVX001 IN A PRE-CLINICAL MODEL OF ACUTE MYELOID LEUKAEMIA Source text for Eikon: Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 GBX | 0.00% |
|
+2.04% | +19.05% |
Jun. 13 | EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss | AN |
Jun. 13 | BiVictriX Therapeutics' Leukemia Treatment Shows Favorable Safety Profile | MT |
Oct 12 (Reuters) - BiVictriX Therapeutics PLC:
* EXTENDED SURVIVAL RATES REPORTED WITH BVX001 IN A PRE-CLINICAL MODEL OF ACUTE MYELOID LEUKAEMIA Source text for Eikon: Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+19.05% | 13.02M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
-12.11% | 26.22B | |
+12.62% | 26.36B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |